Baxter International Inc (BAX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Baxter International Inc (BAX) has a cash flow conversion efficiency ratio of 0.035x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($213.00 Million) by net assets ($6.02 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Baxter International Inc to measure how much of total assets are equity-financed.
Baxter International Inc - Cash Flow Conversion Efficiency Trend (1985–2025)
This chart illustrates how Baxter International Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Baxter International Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Baxter International Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Baxter International Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Moog Inc
NYSE:MOG-A
|
0.062x |
|
WISE PLC SPONS.ADR/1
F:6WS0
|
N/A |
|
Eastroc Beverage Group Co Ltd
SHG:605499
|
0.071x |
|
Aritzia Inc
TO:ATZ
|
0.266x |
|
ViaSat Inc
NASDAQ:VSAT
|
0.068x |
|
Maplebear Inc.
NASDAQ:CART
|
0.103x |
|
American Healthcare REIT, Inc.
NYSE:AHR
|
0.000x |
|
Klepierre SA
PA:LI
|
0.039x |
Annual Cash Flow Conversion Efficiency for Baxter International Inc (1985–2025)
The table below shows the annual cash flow conversion efficiency of Baxter International Inc from 1985 to 2025. For the full company profile with market capitalisation and key ratios, see Baxter International Inc stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $6.10 Billion | $845.00 Million | 0.138x | -4.55% |
| 2024-12-31 | $7.02 Billion | $1.02 Billion | 0.145x | -28.82% |
| 2023-12-31 | $8.47 Billion | $1.73 Billion | 0.204x | -0.78% |
| 2022-12-31 | $5.89 Billion | $1.21 Billion | 0.205x | -15.67% |
| 2021-12-31 | $9.12 Billion | $2.22 Billion | 0.244x | +13.80% |
| 2020-12-31 | $8.73 Billion | $1.87 Billion | 0.214x | -19.50% |
| 2019-12-31 | $7.91 Billion | $2.10 Billion | 0.266x | +3.71% |
| 2018-12-31 | $7.87 Billion | $2.02 Billion | 0.256x | +36.38% |
| 2017-12-31 | $9.12 Billion | $1.71 Billion | 0.188x | -5.88% |
| 2016-12-31 | $8.28 Billion | $1.65 Billion | 0.200x | -0.01% |
| 2015-12-31 | $8.87 Billion | $1.77 Billion | 0.200x | -49.32% |
| 2014-12-31 | $8.16 Billion | $3.21 Billion | 0.394x | +4.60% |
| 2013-12-31 | $8.49 Billion | $3.20 Billion | 0.377x | -15.33% |
| 2012-12-31 | $6.98 Billion | $3.11 Billion | 0.445x | +7.89% |
| 2011-12-31 | $6.83 Billion | $2.82 Billion | 0.413x | -6.63% |
| 2010-12-31 | $6.80 Billion | $3.00 Billion | 0.442x | +12.71% |
| 2009-12-31 | $7.42 Billion | $2.91 Billion | 0.392x | -2.90% |
| 2008-12-31 | $6.23 Billion | $2.52 Billion | 0.404x | +21.14% |
| 2007-12-31 | $6.92 Billion | $2.31 Billion | 0.333x | -4.24% |
| 2006-12-31 | $6.27 Billion | $2.18 Billion | 0.348x | -3.47% |
| 2005-12-31 | $4.30 Billion | $1.55 Billion | 0.361x | -3.20% |
| 2004-12-31 | $3.71 Billion | $1.38 Billion | 0.372x | -14.42% |
| 2003-12-31 | $3.27 Billion | $1.43 Billion | 0.435x | +7.22% |
| 2002-12-31 | $2.94 Billion | $1.19 Billion | 0.406x | +40.43% |
| 2001-12-31 | $3.76 Billion | $1.09 Billion | 0.289x | -34.64% |
| 2000-12-31 | $2.66 Billion | $1.18 Billion | 0.442x | +36.72% |
| 1999-12-31 | $3.35 Billion | $1.08 Billion | 0.323x | -2.20% |
| 1998-12-31 | $2.84 Billion | $939.00 Million | 0.331x | +55.24% |
| 1997-12-31 | $2.62 Billion | $558.00 Million | 0.213x | -32.72% |
| 1996-12-31 | $2.50 Billion | $793.00 Million | 0.317x | -12.20% |
| 1995-12-31 | $3.70 Billion | $1.34 Billion | 0.361x | +1.96% |
| 1994-12-31 | $3.72 Billion | $1.32 Billion | 0.354x | +47.29% |
| 1993-12-31 | $3.19 Billion | $765.00 Million | 0.240x | +19.46% |
| 1992-12-31 | $3.79 Billion | $763.00 Million | 0.201x | +14.33% |
| 1991-12-31 | $4.37 Billion | $769.00 Million | 0.176x | -9.60% |
| 1990-12-31 | $4.09 Billion | $796.00 Million | 0.195x | +33.65% |
| 1989-12-31 | $4.25 Billion | $618.00 Million | 0.146x | -34.55% |
| 1985-12-31 | $2.08 Billion | $463.00 Million | 0.222x | -- |
About Baxter International Inc
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable p… Read more